SEARCH

SEARCH BY CITATION

References

  • 1
    Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005; 28: 176978.
  • 2
    Ford ES, Li C, Sattar N. Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care. 2008; 31: 1898904.
  • 3
    Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002; 287: 3569.
  • 4
    Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005; 28: 27459.
  • 5
    Mattila C, Knekt P, Mannisto S et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care. 2007; 30: 256970.
  • 6
    Knekt P, Laaksonen M, Mattila C et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008; 19: 66671.
  • 7
    Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes. 2008; 57: 261925.
  • 8
    Michos ED, Melamed ML. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care. 2008; 11: 712.
  • 9
    Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome ‘X’? Br J Nutr. 1998; 79: 31527.
  • 10
    Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005; 28: 122830.
  • 11
    Botella-Carretero JI, varez-Blasco F, Villafruela JJ, Balsa JA, Vazquez C, Escobar-Morreale HF. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr. 2007; 26: 57380.
  • 12
    Hypponen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes. 2008; 57: 298305.
  • 13
    Reis JP, von MD, Miller ER III. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol. 2008; 159: 418.
  • 14
    Lu L, Pan A, Hu FB et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese. Diabetes Care. 2009; 32: 127883.
  • 15
    Reis JP, von MD, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care. 2007; 30: 154955.
  • 16
    Rueda S, Fernandez-Fernandez C, Romero F, Martinez de OJ, Vidal J. Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg. 2008; 18: 1514.
  • 17
    Hjelmesaeth J, Hofso D, Aasheim ET et al. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol. 2009; 8: 7.
  • 18
    Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med. 2009; 169: 62632.
  • 19
    Centers for Disease Control and Prevention. NHANES 2005–2006. Available from: http://www.cdc.gov/nchs/about/major/nhanes/nhanes2005-2006/nhanes05_06.htm (accessed 11 May 2009).
  • 20
    Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation. 2005; 112: 273552.
  • 21
    Centers for Disease Control and Prevention. NHANES 2005–2006 Data Documentation Laboratory Assessment: Triglycerides, LDL-Cholesterol, and Apoliprotein. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/trigly_d.pdf (accessed 9 July 2009).
  • 22
    Centers for Disease Control and Prevention. NHANES 2005–2006 Data Documentation. Laboratory Assessment: HDL-Cholesterol. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/hdl_d.pdf (accessed 9 July 2009).
  • 23
    Centers for Disease Control and Prevention. NHANES 2005–2006 Data Documentation. Laboratory Assessment: Plasma Fasting Glucose and Insulin. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/glu_d.pdf (accessed 9 July 2009).
  • 24
    Centers for Disease Control and Prevention. NHANES 2005–2006 Data Documentation. Laboratory Assessment: Vitamin D. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/vid_d.pdf (accessed 9 July 2009).
  • 25
    Centers for Disease Control and Prevention. NHANES 2005–2006 Data Documentation. Laboratory Assessment: Parathyroid Hormone. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/pth_d.pdf (accessed 9 July 2009).
  • 26
    Centers for Disease Control and Prevention. NHANES 2005–2006 Data Documentation. Questionnaire Section: Physical Activity. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/paq_d.pdf (accessed 9 July 2009).
  • 27
    Levey AS, Coresh J, Greene T et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007; 53: 76672.
  • 28
    Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004; 79: 8205.
  • 29
    Liu E, Meigs JB, Pittas AG et al. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr. 2009; 139: 32934.
  • 30
    Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004; 27: 281318.
  • 31
    Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH, Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens. 1995; 8: 894901.
  • 32
    Lind L, Pollare T, Hvarfner A, Lithell H, Sorensen OH, Ljunghall S. Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. Diabetes Res. 1989; 11: 1417.
  • 33
    Baynes KC, Boucher BJ, Feskens EJ, Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia. 1997; 40: 3447.
  • 34
    Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia. 1995; 38: 123945.
  • 35
    Gedik O, Akalin S. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia. 1986; 29: 1425.
  • 36
    Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract. 2003; 57: 25861.
  • 37
    Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care. 2004; 27: 24449.
  • 38
    Cowie CC, Rust KF, Ford ES et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabetes Care. 2009; 32: 28794.
  • 39
    Li C, Ford ES, McGuire LC, Mokdad AH, Little RR, Reaven GM. Trends in hyperinsulinemia among nondiabetic adults in the U.S. Diabetes Care. 2006; 29: 2396402.